Nanoparticles covered with charged ligands can kill errant cancer cells but leave normal cells unharmed
Nanoparticles covered with both positively and negatively charged ligands can target and destroy cancer cells, while getting past the defences of many drug-resistant cancers.
A team led by Bartosz Grzybowski and Kristiana Kandere-Grzybowska at the Institute for Basic Science in Ulsan, South Korea dosed cells with gold nanoparticles attached to thiol ligands, tipped with either quaternary ammonium salts or oxocarbons – each with a net positive or negative charge. The nanoparticles then clustered in cells’ lysosomes – the organelles that carry out recycling, leading Grzybowski to call them the cell’s liver.